BioCentury
ARTICLE | Financial News

Bind Therapeutics completes debt financing

February 2, 2015 8:00 AM UTC

Bind Therapeutics Inc. (NASDAQ:BIND), Cambridge, Mass. Business: Cancer, Drug delivery Date completed: 2015-01-23 Type: Debt financing Raised: $15 million Investor: Hercules Technology Growth Capital ...